SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-05-002829
Filing Date
2005-03-10
Accepted
2005-03-09 20:37:43
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED 12/31/2004 a06565e10vk.htm 10-K 554682
2 EXHIBIT 10.48 a06565exv10w48.txt EX-10.48 2128
3 EXHIBIT 21.1 a06565exv21w1.txt EX-21.1 171
4 EXHIBIT 23.1 a06565exv23w1.txt EX-23.1 1078
5 EXHIBIT 31.1 a06565exv31w1.txt EX-31.1 4302
6 EXHIBIT 31.2 a06565exv31w2.txt EX-31.2 4289
7 EXHIBIT 32.1 a06565exv32w1.txt EX-32.1 1957
  Complete submission text file 0000950137-05-002829.txt   570862
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 05670644
SIC: 2836 Biological Products, (No Diagnostic Substances)